EyeNet Magazine

Products & Services
Academy members: login to read or make comments on this article.

(PDF 117 KB)

Twin Filter Set

Gulden Ophthalmics has introduced a new twin filter set that enhances the visibility of vital stains such as sodium fluorescein and lissamine green used in eye exams.

The Ohlson Vital Stain Enhancement Filter Set features a yellow filter and a red filter, side-by-side, and it is typically used in front of slit-lamp viewing systems. The yellow filter can be used to enhance the visibility of the fluorescein pattern in the examination of the fit of rigid gas permeable contact lenses and silicone hydrogel contact lenses. The red filter is used for red-lens tests and to enhance assessment of dry eye conditions by increasing the visibility of lissamine green staining on the bulbar conjunctiva.

The set comes in a flip-out case that prevents scratching of the filters. The filters and case measure three inches in diameter.

Gulden Ophthalmics
800-659-2250 or


3-D Nonmydriatic Camera

Kowa Optimed has announced that it has received 501(k) approval from the FDA for the marketing of its nonmydriatic 3-D retinal camera for simultaneous stereoscopic retinal photography.

The Nonmyd WX3D Retinal Camera adds the latest in simultaneous stereoscopic photography to its already-integrated normal and small pupil settings. With the addition of 3-D photography of the optic disc, the company intends to provide physicians with the ability to better diagnose glaucoma in their patients.

The camera is also 2-D capable, with a 12-megapixel digital SLR camera intended to deliver extremely detailed retinal images. The integrated nine-points internal fixation system allows for auto mosaic photography covering a large retinal area.

When the camera is connected to Kowa’s Digiversal Open Image Management System, images can be quickly viewed, compared, organized, annotated and shared.

Kowa Optimed
800-966-5692 or


Generic Levofloxacin

Hi-Tech Pharmacal has announced that its abbreviated new drug application for levofloxacin ophthalmic solution 0.5 percent has received final approval from the FDA. The product is indicated for bacterial conjunctivitis and is a generic for Vistakon’s Quixin ophthalmic solution.

Hi-Tech Pharmacal


DISCLAIMER All information and claims are those of the manufacturers and have not been verified, nor does the appearance of the product constitute an endorsement of the company or product by the American Academy of Ophthalmology or EyeNet Magazine.


Academy members: login to read or make comments on this article.
About Us Academy Jobs Privacy Policy Contact Us Terms of Service Medical Disclaimer Site Index